Skip to main content

Medicus Pharma Ltd.

MDCX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001997296

No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.

Other share classesMDCXW

Q2 2026 vs. Q1 2026

How the institutions holding Medicus Pharma Ltd. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of MDCX: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders2123+2
Shares2.32M2.62M+302.3K (+13.0%)
Value$301.6K$1.18M+$878.1K (+291.2%)

New holders (9)

Institutions that held Medicus Pharma Ltd. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to MDCX in Q2 2026
InstitutionSharesValue% of portfolio
Jane Street Group, LLC333,673$148.9K0.00%
XTX Topco Ltd243,362$108.6K0.00%
Sterling Investment Advisors, Ltd.100,000$44.6K0.01%
Susquehanna International Group, LLP31,462$14.0K0.00%
Stifel Financial Corp30,000$13.4K0.00%
JPMorgan Chase & Co25,622$12.5K0.00%
Stratos Wealth Partners, LTD.20,950$9.35K0.00%
Foundations Investment Advisors, LLC11,000$4.91K0.00%
Royal Bank of Canada1,055$00.00%

Sold out (7)

Institutions that held Medicus Pharma Ltd. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of MDCX in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Private Advisor Group, LLC240,055$110.2K
Virtu Financial LLC74,045$34.0K
UBS Group AG40,441$18.6K
BlackRock, Inc.37,294$17.1K
Two Sigma Securities, LLC15,617$7.17K
Brave Asset Management Inc10,000$4.56K
Tower Research Capital LLC (TRC)121$56